scholarly journals A common underlying genetic contribution to the co-occurrence of depressive symptoms and lower blood pressure in adolescents

2018 ◽  
Vol 1 (1) ◽  
pp. 01-05
Author(s):  
Yuan Ko Wang ◽  
Jun- Ming Xu

Background: Depression and cardiovascular disease risk factors develop in childhood. The objective of this study was to investigate cross sectional and longitudinal associations between blood pressure, mood scores and tagged SNPs within the Monoamine oxidase A (MAOA) gene in the Western Australian Pregnancy Cohort (Raine) Study. Methods: Data from the five (n=1097), eight (n=1046), ten (n=1026) and fourteen (n=1124) year surveys were used. Blood pressure was measured at all surveys, anxious-depressed scores obtained from the Childhood Behavior Checklist at all surveys and depressive symptom scores from the Beck Depression Inventory for Youth at 14 years. Single nucleotide polymorphisms (SNPs) tagging the MAOA gene were identified from HapMap Phase II (CEU) data and genotyped. Cross sectional and longitudinal analyses were used to examine the association between blood pressure (outcome) and tagged SNPs within the MAOA gene and anxious/depressed scores (outcome) and tagged SNPs within the MAOA gene. Results: At 14 years, boys with the risk allele of SNP rs5905859 and rs3027396 had higher systolic blood pressure (βrs5905859=2.5; 95% CI: 0.743, 4.337 and βrs3027396=2.5; 95% CI: 0.681, 4.383 respectively) and lower mood scores (βrs5905859=-0.1; 95% CI: -0.100, -0.022 and βrs3027396=-0.2; 95% CI: -0.313,-0.045 respectively). Longitudinally, boys with the risk allele of SNPs rs5905859 (β=0.3; 95% CI: 0.026, 0.540) or rs6609257 (β= 0.3; 95% CI: 0.022, 0.521) had a higher mean systolic blood pressure trajectory compared to boys without. Conclusions: Variation within or close to the MAOA gene may explain in part the association between lower depressive symptom scores and higher systolic blood pressure in Caucasian boys within the Raine cohort.

Author(s):  
Alexander C. Razavi, ◽  
Camilo Fernandez ◽  
Jiang He ◽  
Tanika N. Kelly ◽  
Marie Krousel-Wood ◽  
...  

Background: Elevated cardiovascular disease risk factor burden is a recognized contributor to poorer cognitive function; however, the physiological mechanisms underlying this association are not well understood. We sought to assess the potential mediation effect of left ventricular (LV) remodeling on the association between lifetime systolic blood pressure and cognitive function in a community-based cohort of middle-aged adults. Methods: Nine hundred sixty participants of the Bogalusa Heart Study (59.2% women, 33.8% black, aged 48.4±5.1 years) received 2-dimensional echocardiography to quantify relative wall thickness, LV mass, and diastolic and systolic LV function; and a standardized neurocognitive battery to assess memory, executive functioning, and language processing. Multivariable linear regression assessed the association of cardiac structure and function with a global composite cognitive function score, adjusting for traditional cardiovascular disease risk factors. Mediation analysis assessed the effect of LV mass index on the association between lifetime systolic blood pressure burden and cognitive function. Results: There were 233 (24.3%) and 136 (14.2%) individuals with concentric LV remodeling and concentric LV hypertrophy, respectively. Each g/m 2.7 increment in LV mass index was associated with a 0.03 standardized unit decrement in global cognitive function ( P =0.03). Individuals with concentric LV remodeling and isolated diastolic dysfunction had the poorest cognitive function, and a greater ratio between early mitral inflow velocity and early diastolic mitral annular velocity (E/e’) was associated with poorer cognitive function, even after adjustment for LV mass index (B=−0.12; P =0.03). A total of 18.8% of the association between lifetime systolic blood pressure burden and midlife cognitive function was accounted for by LV mass index. Conclusions: Cardiac remodeling partially mediates the association between lifespan systolic blood pressure burden and adult cognition in individuals without dementia or clinical cardiovascular disease. Slowing or reversing the progression of cardiac remodeling in middle-age may be a novel therapeutic approach to prevent cognitive decline.


2009 ◽  
Vol 102 (7) ◽  
pp. 1065-1074 ◽  
Author(s):  
Sarah Egert ◽  
Anja Bosy-Westphal ◽  
Jasmin Seiberl ◽  
Claudia Kürbitz ◽  
Uta Settler ◽  
...  

Regular consumption of flavonoids may reduce the risk for CVD. However, the effects of individual flavonoids, for example, quercetin, remain unclear. The present study was undertaken to examine the effects of quercetin supplementation on blood pressure, lipid metabolism, markers of oxidative stress, inflammation, and body composition in an at-risk population of ninety-three overweight or obese subjects aged 25–65 years with metabolic syndrome traits. Subjects were randomised to receive 150 mg quercetin/d in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 5-week washout period. Mean fasting plasma quercetin concentrations increased from 71 to 269 nmol/l (P < 0·001) during quercetin treatment. In contrast to placebo, quercetin decreased systolic blood pressure (SBP) by 2·6 mmHg (P < 0·01) in the entire study group, by 2·9 mmHg (P < 0·01) in the subgroup of hypertensive subjects and by 3·7 mmHg (P < 0·001) in the subgroup of younger adults aged 25–50 years. Quercetin decreased serum HDL-cholesterol concentrations (P < 0·001), while total cholesterol, TAG and the LDL:HDL-cholesterol and TAG:HDL-cholesterol ratios were unaltered. Quercetin significantly decreased plasma concentrations of atherogenic oxidised LDL, but did not affect TNF-α and C-reactive protein when compared with placebo. Quercetin supplementation had no effects on nutritional status. Blood parameters of liver and kidney function, haematology and serum electrolytes did not reveal any adverse effects of quercetin. In conclusion, quercetin reduced SBP and plasma oxidised LDL concentrations in overweight subjects with a high-CVD risk phenotype. Our findings provide further evidence that quercetin may provide protection against CVD.


2013 ◽  
Vol 45 (6) ◽  
pp. 237-242 ◽  
Author(s):  
Shumpei Fujie ◽  
Motoyuki Iemitsu ◽  
Haruka Murakami ◽  
Kiyoshi Sanada ◽  
Hiroshi Kawano ◽  
...  

Fatty acid binding protein 2 (FABP2) Ala54Thr polymorphism is a candidate gene associated with the risk of cardiovascular disease. Habitual exercise brings higher cardiorespiratory fitness and results in the improvement of cardiovascular disease risk. However, the effect of cardiorespiratory fitness level and FABP2 Ala54Thr polymorphism on the risk of cardiovascular diseases remains unclear. In the present study, a cross-sectional investigation of 837 Japanese men and women was performed to clarify the effects of cardiorespiratory fitness on the relationship between risk of cardiovascular disease and FABP2 Ala54Thr gene polymorphism. The study subjects were divided into high-cardiorespiratory fitness (High-Fit) and low-cardiorespiratory fitness (Low-Fit) groups based on the median value of peak oxygen uptake in each sex and decade. The FABP2 Ala54Thr polymorphism did not significantly affect carotid β-stiffness or blood pressure. In the Low-Fit group, carotid β-stiffness, systolic blood pressure, and diastolic blood pressure were higher for individuals with the Ala/Ala genotype compared with those with the Ala/Thr or Thr/Thr genotype, whereas no differences were observed in the High-Fit group. Additionally, serum triglyceride and plasma glucose levels were lower and serum high-density lipoprotein cholesterol levels were higher in the High-Fit group compared with the Low-Fit group; the FABP2 Ala54Thr polymorphism did not significantly affect these parameters. These results suggest that the higher cardiorespiratory fitness may attenuate the changes in central arterial stiffness and blood pressure that are associated with the FABP2 genotype.


2014 ◽  
Vol 8 (3) ◽  
pp. 159-165 ◽  
Author(s):  
Siqin Ye ◽  
Y. Claire Wang ◽  
Daichi Shimbo ◽  
Jonathan D. Newman ◽  
Emily B. Levitan ◽  
...  

Medicina ◽  
2021 ◽  
Vol 57 (4) ◽  
pp. 384
Author(s):  
Serkan Yüksel ◽  
Metin Çoksevim ◽  
Murat Meriç ◽  
Mahmut Şahin

Background and Objectives: An inter-arm systolic blood pressure difference (IASBPD) is defined as a blood pressure (BP) disparity of ≥10 mmHg between arms. IASBPDs are associated with an increased risk of cardiovascular disease (CVD). Similarly, visceral fat accumulation (VFA) is clinically important because it is associated with higher cardiovascular disease risk. Accordingly, this study compared the body composition parameters of IASBPD individuals with individuals who did not express an IASBPD. Materials and Methods: The analysis included 104 patients. The blood pressures of all participants were measured simultaneously in both arms using automated oscillometric devices. Then patients were divided into two groups according to their IASBPD status: Group 1 (IASBPD- (<10 mmHg)); Group 2 (IASPPD+ (≥10 mmHg)). Body composition parameters were measured using bioelectrical impedance analysis. Results: In 42 (40%) patients, the simultaneously measured IASBPD was equal to or higher than 10 mmHg. The right brachial SBP was higher in 63% of patients. There were no differences between the groups in terms of demographic and clinical characteristics. Regarding the two groups’ body composition parameter differences, VFA was significantly higher in group 2 (p = 0.014). Conclusions: The IASBPD is known to be associated with an increased risk of cardiovascular events. Although the body mass indexes (BMIs) of the two groups were similar, VFA levels in those with a greater than 10 mmHg IASBPD were found to be significantly higher. This finding may explain the increased cardiovascular risk in this group.


Sign in / Sign up

Export Citation Format

Share Document